Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases

Smith, 1989, The eicosanoids and their biochemical mechanisms of action, Biochem. J., 259, 315, 10.1042/bj2590315

Berenbaum, 2000, Proinflammatory cytokines, prostaglandins, and the chodrocyte: mechanisms of intracellular activation, Jt. Bone Spine, 67, 561, 10.1016/S1297-319X(00)00212-8

Funk, 2001, Prostaglandins and leukotrienes: advances in eicosanoid biology, Science, 294, 1871, 10.1126/science.294.5548.1871

Serhan, 2003, Success of prostaglandin E2 in structure–function is a challenge for structure-based therapeutics, Proc. Natl. Acad. Sci. U. S. A., 100, 8609, 10.1073/pnas.1733589100

Sugimoto, 2000, Distribution and function of prostanoid receptors: studies from knockout mice, Prog. Lipid Res., 39, 289, 10.1016/S0163-7827(00)00008-4

Davies, 1984, The role of arachidonic acid oxygenation products in pain and inflammation, Annu. Rev. Immunol., 2, 335, 10.1146/annurev.iy.02.040184.002003

Takayama, 2002, Prostaglandin E2 suppresses cytokine production in human macrophages through the EP4 receptor, J. Biol. Chem., 277, 44147, 10.1074/jbc.M204810200

Vane, 2003, The mechanism of action of aspirin, Thromb. Res., 110, 255, 10.1016/S0049-3848(03)00379-7

Smith, 2000, Cyclooxygenases: structural, cellular and molecular biology, Annu. Rev. Biochem., 69, 145, 10.1146/annurev.biochem.69.1.145

Leslie, 2004, Regulation of arachidonic acid availability for eicosanoid production, Biochem. Cell. Biol., 82, 1, 10.1139/o03-080

Bingham, 1999, Phospholipase A2 enzymes in eicosanoid generation, Proc. Assoc. Am. Phys., 111, 516, 10.1046/j.1525-1381.1999.99321.x

Murakami, 2004, Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway, Prog. Lipid Res., 43, 3, 10.1016/S0163-7827(03)00037-7

Kudo, 2002, Phospholipase A2 enzymes, Prostaglandins Other Lipid Mediat., 68–69, 3, 10.1016/S0090-6980(02)00020-5

Balsinde, 1995, Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages, Proc. Natl. Acad. Sci. U. S. A., 92, 8527, 10.1073/pnas.92.18.8527

Leslie, 2004, Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2, Prostaglandins, Leukotrienes Essent. Fatty Acids, 70, 373, 10.1016/j.plefa.2003.12.012

Clark, 1991, A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP, Cell, 65, 1043, 10.1016/0092-8674(91)90556-E

Evans, 2004, The cytosolic phospholipase A2 catalytic domain modulates association and residence time at Golgi membranes, J. Biol. Chem., 279, 6005, 10.1074/jbc.M311246200

Lin, 1993, cPLA2 is phosphorylated and activated by MAP kinase, Cell, 72, 269, 10.1016/0092-8674(93)90666-E

Hefner, 2000, Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases, J. Biol. Chem., 275, 37542, 10.1074/jbc.M003395200

Muthalif, 2001, Functional interaction of calcium-/calmodulin-dependent protein kinase II and cytosolic phospholipase A(2), J. Biol. Chem., 276, 39653, 10.1074/jbc.M103136200

Uozumi, 1997, Role of cytosolic phospholipase A2 in allergic response and parturition, Nature, 390, 618, 10.1038/37622

Bonventre, 1997, Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2, Nature, 390, 622, 10.1038/37635

Wong, 2002, Discrete role for cytosolic phospholipase A(2)alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2), J. Exp. Med., 196, 349, 10.1084/jem.20011443

Hegen, 2003, Cytosolic phospholipase A2alpha-deficient mice are resistant to collagen-induced arthritis, J. Exp. Med., 197, 1297, 10.1084/jem.20030016

Vane, 1971, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin like drugs, Nat. Biol., 231, 232, 10.1038/newbio231232a0

Hemler, 1976, Purification of the cyclooxygenase that forms prostaglandins. Demonstration of two forms of iron in the holoenzyme, J. Biol. Chem., 251, 5575, 10.1016/S0021-9258(17)33098-3

DeWitt, 1988, Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence, Proc. Natl. Acad. Sci. U. S. A., 85, 1412, 10.1073/pnas.85.5.1412

Merlie, 1988, Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase), J. Biol. Chem., 263, 3550, 10.1016/S0021-9258(18)68959-8

Yokoyama, 1988, Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequence, FEBS Lett., 231, 347, 10.1016/0014-5793(88)80847-0

Smith, 1986, Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells, Annu. Rev. Physiol., 48, 251, 10.1146/annurev.ph.48.030186.001343

Kirtland, 1988, Prostaglandin E1: a review, Prostaglandins, Leukotrienes Essent. Fatty Acids, 32, 165, 10.1016/0952-3278(88)90168-8

Funk, 1991, Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosome assignment, FASEB J., 5, 2304, 10.1096/fasebj.5.9.1907252

Tay, 1994, Assignment of the human prostaglandin-endoperoxide synthase 2 (PTGS2) gene to 1q25 by fluorescence in situ hybridization, Genomics, 23, 718, 10.1006/geno.1994.1569

Tanabe, 2002, Cyclooxygenase isozymes and their gene structures and expression, Prostaglandins Other Lipid Mediators, 68–69, 95, 10.1016/S0090-6980(02)00024-2

Morita, 2002, Distinct functions of COX-1 and COX-2, Prostaglandins Other Lipid Mediators, 68–69, 165, 10.1016/S0090-6980(02)00029-1

Kurumbail, 1996, Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents, Nature, 384, 644, 10.1038/384644a0

Luong, 1996, Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2, Nat. Struct. Biol., 3, 927, 10.1038/nsb1196-927

Roth, 1975, Acetylation of prostaglandin synthetase by aspirin, Proc. Natl. Acad. Sci. U. S. A., 72, 3073, 10.1073/pnas.72.8.3073

Serhan, 2000, Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing, J. Exp. Med., 192, 1197, 10.1084/jem.192.8.1197

Gierse, 1996, A single amino acid difference between cyclooxygenase-1 (COX-1) and-2 (COX-2) reverses the selectivity of COX-2 specific inhibitors, J. Biol. Chem., 271, 15810, 10.1074/jbc.271.26.15810

Habeeb, 2001, Design and synthesis of celecoxib and rofecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of sulfonamide and methylsulfonyl pharmacophores by an azido bioisostere, J. Med. Chem., 44, 3039, 10.1021/jm010153c

Shitashige, 1998, Different substrate utilization between prostaglandin endoperoxide H synthase-1 and-2 in NIH3T3 fibroblasts, Biochim. Biophys. Acta, 1389, 57, 10.1016/S0005-2760(97)00129-X

Morita, 1995, Different intracellular locations for prostaglandin endoperoxide H synthase-1 and-2, J. Biol. Chem., 270, 10902, 10.1074/jbc.270.18.10902

Spencer, 1998, Subcellular localization of prostaglandin endoperoxide H synthases-1 and-2 by immunoelectron microscopy, J. Biol. Chem., 273, 9886, 10.1074/jbc.273.16.9886

Flower, 1972, Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol), Nature, 240, 410, 10.1038/240410a0

Chandrasekharan, 2002, COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression, Proc. Natl. Acad. Sci. U. S. A., 99, 13926, 10.1073/pnas.162468699

Botting, 2005, COX-3 and the mechanism of action of paracetamol/acetaminophen, Prostaglandins, Leukotrienes Essent. Fatty Acids, 72, 85, 10.1016/j.plefa.2004.10.005

Roos, 2005, Cyclooxygenase variants: the role of alternative splicing, Biochem. Biophys. Res. Commun., 338, 62, 10.1016/j.bbrc.2005.08.031

Zurier, 2005, Prostaglandins, leukotrienes, and related compounds, 356

Ogino, 1977, Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsomes, a glutathione-requiring enzyme, J. Biol. Chem., 252, 890, 10.1016/S0021-9258(19)75182-5

Moonen, 1982, Purification of PGH-PGE isomerase from sheep vesicular glands, vol. 86

Ouellet, 2002, Purification and characterization of recombinant microsomal prostaglandin E synthase-1, Protein Expression Purif., 26, 489, 10.1016/S1046-5928(02)00566-1

Jakobsson, 1999, Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target, Proc. Natl. Acad. Sci. U. S. A., 96, 7220, 10.1073/pnas.96.13.7220

Jakobsson, 1999, Common structural features of MAPEG-A widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism, Protein Sci., 8, 689, 10.1110/ps.8.3.689

Murakami, 2003, Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2, J. Biol. Chem., 275, 32783, 10.1074/jbc.M003505200

Thoren, 2000, Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells: inhibition by NS-398 and leukotriene C4, Eur. J. Biochem., 267, 6428, 10.1046/j.1432-1327.2000.01735.x

Forsberg, 2000, Human glutathione dependent prostaglandin E synthase: gene structure and regulation, FEBS Lett., 471, 78, 10.1016/S0014-5793(00)01367-3

Tanioka, 2000, Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis, J. Biol. Chem., 275, 32775, 10.1074/jbc.M003504200

Thoren, 2003, Human microsomal prostaglandin E synthase-1: purification, functional characterization, and projection structure determination, J. Biol. Chem., 278, 22209, 10.1074/jbc.M303227200

Masuko-Hongo, 2004, Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways, Arthritis Rheum., 50, 2829, 10.1002/art.20437

Naraba, 2002, Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene: essential role of the transcription factor Egr-1, J. Biol. Chem., 277, 28601, 10.1074/jbc.M203618200

Scher, 2005, 15d-PGJ2: the anti-inflammatory prostaglandin?, Clin. Immunol., 114, 100, 10.1016/j.clim.2004.09.008

Lemberger, 1996, Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology, Annu. Rev. Cell Dev. Biol., 12, 335, 10.1146/annurev.cellbio.12.1.335

Fahmi, 2002, PPAR gamma ligands as modulators of inflammatory and catabolic responses in arthritis: an overview, J. Rheumatol., 29, 3

Bianchi, 2005, Contrasting effects of peroxisome–proliferator-activated receptor (PPAR)γ agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1b-stimulated rat chondrocytes: evidence for PPARg-independent inhibition by 15-deoxy-D12,14prostaglandin J2, Arthritis Res. Ther., 7, R1325, 10.1186/ar1830

Kawahito, 2000, 15-Deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats, J. Clin. Invest., 189, 10.1172/JCI9652

Li, 2005, Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes, J. Rheumatol., 32, 887

Cheng, 2004, Activation of peroxisome proliferator-activated receptor g inhibits interleukin-1b-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1, J. Biol. Chem., 279, 22057, 10.1074/jbc.M402828200

Vazquez-Tello, 2004, Intracellular-specific colocalization of prostaglandin E2 synthases and cyclooxygenases in the brain, Am. J. Physiol.: Regul., Integr. Comp. Physiol., 287, R1155, 10.1152/ajpregu.00077.2004

Pillinger, 2005, Expression and subcellular localization of COX 1 and 2 and their associated terminal synthases, cPGES and mPGES-1, in IL-1β-stimulated chondrocytes, Arthritis Rheum., 152, S475

Tanioka, 2003, Regulation of cytosolic prostaglandin E2 synthase by 90-kDa heat shock protein, Biochem. Biophys. Res. Commun., 303, 1018, 10.1016/S0006-291X(03)00470-4

Kobayashi, 2004, Regulation of cytosolic prostaglandin E synthase by phosphorylation, Biochem. J., 381, 59, 10.1042/BJ20040118

Watanabe, 1997, Two types of microsomal prostaglandin E synthase: glutathione-dependent and -independent prostaglandin E synthases, Biochem. Biophys. Res. Commun., 235, 148, 10.1006/bbrc.1997.6708

Tanikawa, 2002, Identification and characterization of a novel type of membrane-associated prostaglandin E synthase, Biochem. Biophys. Res. Commun., 291, 884, 10.1006/bbrc.2002.6531

Yamada, 2005, Crystal structure and possible catalytic mechanism of microsomal prostaglandin E synthase type 2 (mPGES-2), J. Mol. Biol., 348, 1163, 10.1016/j.jmb.2005.03.035

Watanabe, 2003, Essential 110Cys in active site of membrane-associated prostaglandin E synthase-2, Biochem. Biophys. Res. Commun., 306, 577, 10.1016/S0006-291X(03)01025-8

Murakami, 2003, Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2, J. Biol. Chem., 278, 37937, 10.1074/jbc.M305108200

Bombardier, 1981, The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and non-steroidal anti-inflammatory drugs, Br. J. Pharmacol., 73, 893, 10.1111/j.1476-5381.1981.tb08743.x

Hardy, 2002, Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants, Arthritis Rheum., 46, 1789, 10.1002/art.10356

Westman, 2004, Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium, Arthritis Rheum., 50, 1774, 10.1002/art.20286

Korotkova, 2005, Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway, Arthritis Rheum., 52, 3439, 10.1002/art.21390

Stichtenoth, 2001, Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells, J. Immunol., 167, 469, 10.4049/jimmunol.167.1.469

Kojima, 2002, Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells, J. Rheumatol., 29, 1836

Kojima, 2004, Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis, Arthritis Res. Ther., 6, R355, 10.1186/ar1195

Claveau, 2003, Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model, J. Immunol., 170, 4738, 10.4049/jimmunol.170.9.4738

Mancini, 2001, Cloning, expression, and up-regulation of inducible rat prostaglandin E synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis, J. Biol. Chem., 276, 4469, 10.1074/jbc.M006865200

Engblom, 2002, Induction of microsomal prostaglandin E synthase in the rat brain endothelium and parechyma in adjuvant-induced arthritis, J. Comp. Neurol., 452, 205, 10.1002/cne.10380

Guay, 2004, Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1, J. Biol. Chem., 279, 24866, 10.1074/jbc.M403106200

Uematsu, 2002, Lipopolysaccharide-dependent prostaglandin E2 production is regulated by the glutathione-dependent prostaglandin E2 synthase gene induced by the toll-like receptor 4/MyD88/NF-IL6 pathway, J. Immunol., 168, 5811, 10.4049/jimmunol.168.11.5811

Kamei, 2004, Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1, J. Biol. Chem., 279, 33684, 10.1074/jbc.M400199200

Trebino, 2003, Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase, Proc. Natl. Acad. Sci. U. S. A., 100, 9044, 10.1073/pnas.1332766100

Schuster, 2002, Prostaglandin transport, Prostaglandins Other Lipid Mediators, 68–69, 633, 10.1016/S0090-6980(02)00061-8

Chan, 1998, Mechanism of prostaglandin E2 transport across the plasma membrane of HeLa cells and Xenopus oocytes expressing the prostaglandin transporter “PGT”, J. Biol. Chem., 273, 6689, 10.1074/jbc.273.12.6689

Kanai, 1995, Identification and characterization of a prostaglandin transporter, Science, 268, 866, 10.1126/science.7754369

Reid, 2003, The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal anti-inflammatory drugs, Proc. Natl. Acad. Sci. U. S. A., 100, 9244, 10.1073/pnas.1033060100

Amin, 1996, Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage: influence of nitric oxide, J. Clin. Invest., 99, 1231, 10.1172/JCI119280

Cheng, 2002, Role of prostacyclin in the cardiovascular response to thromboxane A2, Science, 296, 539, 10.1126/science.1068711